Acanthamoeba castellaniiAmebiasisContinuous Positive Airway Pressure
Dr. Robin Marie M. Joyce, MD
NPI1659318350PAC ID9234209974
- Medicare services, 2024
- 304
- Medicare patients, 2024
- 81
- Part D claims, 2023
- 12
- Publications
- 3
- Clinical trials
- 3
- Practice address
- 330 Brookline Avenue, Boston, MA 02215
- Practice phone
- Call (617) 667-7000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Joyce's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Robin Marie M. Joyce is a hematologist and oncologist in Boston, Massachusetts
Dr. Joyce practices at Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health.
Dr. Joyce's NPI, 1659318350, was assigned on June 1, 2006. Dr. Joyce graduated from University of Massachusetts Medical School in 1991. Dr. Joyce holds Massachusetts license 81541.
NPI and contact details
- NPI
- 1659318350NPI Registry (opens in a new tab)
- Medicare PAC ID
- 9234209974
- NPI enumeration date
- June 1, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (617) 667-7000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 61
- Medical school graduation
- 1991
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Robin Marie M. Joyce practices at Beth Israel Deaconess Medical Center in Boston, Massachusetts
Dr. Joyce's primary practice is Beth Israel Deaconess Medical Center, at 330 Brookline Avenue, Boston, MA 02215 in Suffolk County. The practice phone is (617) 667-7000.
- Beth Israel Deaconess Medical Center330 Brookline Avenue, Boston, MA 02215 · Suffolk CountyPhone(617) 667-7000
Source: Dmand AI Affiliation Data
Dr. Robin Marie M. Joyce is affiliated with 1 site of care and 3 medical groups
Dr. Joyce's primary practice is Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP). Dmand AI also links Dr. Joyce to 2 more medical groups, each named with a free account.
Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP)2 medical groupsNames with a free account
See all 4 affiliations for Dr. JoyceSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Robin Marie M. Joyce's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Joyce practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Beth Israel Deaconess Medical Center | Available with a free account |
| +2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Joyce practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Beth Israel Lahey Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Robin Marie M. Joyce is one of 429 hematologists and oncologists in Massachusetts
Hematology and oncology is Dr. Joyce's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Joyce is licensed in Massachusetts.
Specialties and state licenses
- Hematology and oncology, MassachusettsPrimary
Hematologists and oncologists near Dr. Joyce
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
429hematologists and oncologists in Massachusetts224hematologists and oncologists in Boston29hematologists and oncologists at Beth Israel Deaconess Medical Center
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Robin Marie M. Joyce billed Medicare for 304 services in 2024
CMS data shows 304 Medicare services from Dr. Joyce across 3 procedure codes in 2024, for 81 Medicare patients. Medicare paid $24,671 for them. Every service was in a facility, such as a hospital, rather than an office.
Medicare services, 2024304
Medicare patients81
Paid by Medicare$24,671
Procedure codes3
Dr. Joyce's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 2392024: 30427%
Dr. Joyce compared with the Massachusetts median for hematologists and oncologists, 2024
- Dr. Joyce
- Massachusetts median
- Medicare services
- 304vs 49539% below
- Medicare patients
- 81vs 20060% below
- Part D claims
- 12vs 15192% below
Medians across 415 hematologists and oncologists in Massachusetts with Dmand AI profiles that report each measure.
Dr. Joyce's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Joyce?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Joyce and other hematologists and oncologists in Massachusetts.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Robin Marie M. Joyce treated 81 Medicare patients in 2024, average age 75
CMS counts 81 Medicare patients who saw Dr. Joyce in 2024. The largest group is 75 to 84, with 37 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 3.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Joyce's median patient age at 71, with 47% women.
Medicare patients, 202481
Average age75
Average risk score3.35
Also on Medicaid23%
Dr. Joyce's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Joyce's Medicare patients by sex, 2024
- Women4758%
- Men3442%
Chronic conditions among Dr. Joyce's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Heart failure49%
- Chronic kidney disease48%
- Arthritis47%
- Anxiety42%
- Mood disorders38%
- Depression36%
Share of Medicare patients with each condition. A patient can have several.
Dr. Joyce's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 71
Patient panel by sex, all payers
- Women47%
- Men51%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Robin Marie M. Joyce wrote 12 Medicare Part D claims in 2023
In 2023, Dr. Joyce wrote 12 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $104 in total drug cost. In 2022, CMS named 17 claims across 1 drug.
Part D claims, 202312
Drugs named by CMS1
Total drug cost$104
Dr. Joyce's most prescribed drugs by claims, 2023
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2022 to 2023
- 2022
- 2023
- Claims for drugs CMS names
- 2022: 172023: 1229%
Drugs named by CMS: 1 in 2023, 1 in 2022.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
How Dr. Robin Marie M. Joyce takes part in Medicare
Dr. Joyce accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Joyce by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Robin Marie M. Joyce has 3 publications on record
Dmand AI links 3 papers to Dr. Joyce, published from 2012 to 2017. Dr. Joyce's most frequent co-authors are Andrew S. Artz, MD, MS, Edward D. Ball, MD and Robert Brian Berryman, MD.
Papers3
Years published2012 to 2017
Dr. Joyce's papers by year, 2012 to 2017
Dr. Joyce's most frequent co-authors
- Andrew S. Artz, MD, MS1 shared paper
- Edward D. Ball, MD1 shared paper
- Robert Brian Berryman, MD1 shared paper
Recent publications by Dr. Joyce
Bone Marrow Transplant
Anti-HIV AgentsBenzylaminesBlood Component Removal
See who Dr. Joyce researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Joyce works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Robin Marie M. Joyce has worked on 3 clinical trials
Dmand AI links Dr. Joyce to 3 clinical trials, 2 of them phase 1 studies. Conditions studied include Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia-Lymphoma, Adult T-Cell and Lymphoma, Follicular.
Clinical trials with Dr. Joyce by phase
- 2Phase 1: 2 trials
- 1Phase 1/2: 1 trial
- NonePhase 2: no trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Joyce's trials
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia-Lymphoma, Adult T-Cell
- Lymphoma, Follicular
- Leukemia, B-Cell
- Leukemia, T-Cell
Investigators on the most trials with Dr. Joyce
- Ahmad Sami Halwani, MD2 shared trials
- Lihua Elizabeth Budde, MD, PhD1 shared trial
- Madeleine Duvic, MD1 shared trial
Recent clinical trials with Dr. Joyce
A Phase I/II Study of Pyrimethamine, a STAT3 Inhibitor, for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (opens in a new tab)
CompletedPhase 1/2
Leukemia, Lymphocytic, Chronic, B-CellLeukemia, B-CellPyrimethamine
Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL (opens in a new tab)
CompletedPhase 1
Leukemia-Lymphoma, Adult T-CellLeukemia, T-CellCobomarsen
A Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin Lymphoma (opens in a new tab)
TerminatedPhase 1
Lymphoma, FollicularLymphoma, Large B-Cell, DiffuseSGN-CD19B
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Robin Marie M. Joyce received $17 in industry payments in 2016
CMS Open Payments shows 1 general payment to Dr. Joyce from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $17. It also lists 8 research payments totaling $11,414 from 2019 to 2022.
Companies that paid Dr. Joyce the most, 2016 to 2016
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Robin Marie M. Joyce graduated from University of Massachusetts Medical School
Dr. Joyce graduated from University of Massachusetts Medical School in 1991.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Robin Marie M. Joyce's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Robin Marie M. Joyce
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Robin Marie M. Joyce's NPI number?
Dr. Robin Marie M. Joyce's NPI number is 1659318350. It was assigned on June 1, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Robin Marie M. Joyce?
Dr. Robin Marie M. Joyce is a hematologist and oncologist in Boston, Massachusetts. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Robin Marie M. Joyce practice?
Dr. Joyce practices at 330 Brookline Avenue, Boston, MA 02215. Dr. Joyce's primary practice is Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health. Dmand AI also links Dr. Joyce to 2 medical groups.
What is Dr. Robin Marie M. Joyce's office phone number?
The practice phone on file for Dr. Joyce is (617) 667-7000.
What is Dr. Robin Marie M. Joyce's medical license number?
Dr. Joyce holds Massachusetts license 81541.
Which hospitals is Dr. Robin Marie M. Joyce affiliated with?
Dr. Joyce practices at Beth Israel Deaconess Medical Center in Boston, Massachusetts.
What medical group is Dr. Robin Marie M. Joyce part of?
Dr. Joyce is linked to Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP). Dmand AI links Dr. Joyce to 2 more medical groups.
Does Dr. Robin Marie M. Joyce accept Medicare?
Yes. CMS data shows Dr. Joyce billed Medicare for 304 services in 2024, and Dr. Joyce accepts Medicare assignment.
How many Medicare patients does Dr. Robin Marie M. Joyce see?
CMS counts 81 Medicare patients who saw Dr. Joyce in 2024, with an average age of 75.
What services does Dr. Robin Marie M. Joyce bill to Medicare?
In 2024, Dr. Joyce's most billed Medicare services were hospital inpatient care (99232), hospital inpatient care (99233) and hospital inpatient care (99239).
Show 6 more questionsShow fewer questions
Where did Dr. Robin Marie M. Joyce go to medical school?
Dr. Joyce graduated from University of Massachusetts Medical School in 1991.
What drugs does Dr. Robin Marie M. Joyce prescribe most?
In 2023 Medicare Part D data, Dr. Joyce's most prescribed drugs by claims were Acyclovir.
Has Dr. Robin Marie M. Joyce received payments from drug or device companies?
CMS Open Payments shows $17 in general payments to Dr. Joyce from 1 company from 2016 to 2016. The largest total came from Genentech, Inc.
How long has Dr. Robin Marie M. Joyce been practicing?
Dr. Joyce graduated from medical school in 1991, 35 years ago.
Does Dr. Robin Marie M. Joyce do research?
Dmand AI links 3 publications to Dr. Joyce, published from 2012 to 2017. Dr. Joyce has worked on 3 clinical trials.
Who does Dr. Robin Marie M. Joyce publish with?
Dr. Joyce's most frequent co-authors are Andrew S. Artz, MD, MS (1 shared paper), Edward D. Ball, MD (1 shared paper) and Robert Brian Berryman, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in Massachusetts by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card